• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用灌胃给药技术对氟喹诺酮类药物在家兔眼部渗透的制剂因素进行综合评价。

Comprehensive evaluation of formulation factors for ocular penetration of fluoroquinolones in rabbits using cassette dosing technique.

作者信息

Sharma Charu, Biswas Nihar R, Ojha Shreesh, Velpandian Thirumurthy

机构信息

Department of Ocular Pharmacology and Pharmacy, All India Institute of Medical Sciences, New Delhi, India; Department of Internal Medicine, United Arab Emirates University, Al Ain, UAE.

Department of Ocular Pharmacology and Pharmacy, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Drug Des Devel Ther. 2016 Feb 22;10:811-23. doi: 10.2147/DDDT.S95870. eCollection 2016.

DOI:10.2147/DDDT.S95870
PMID:26955263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4769009/
Abstract

OBJECTIVE

Corneal permeability of drugs is an important factor used to assess the efficacy of topical preparations. Transcorneal penetration of drugs from aqueous formulation is governed by various physiological, physiochemical, and formulation factors. In the present study, we investigated the effect of formulation factors like concentration, pH, and volume of instillation across the cornea using cassette dosing technique for ophthalmic fluoroquinolones (FQs).

MATERIALS AND METHODS

Sterile cocktail formulations were prepared using four congeneric ophthalmic FQs (ofloxacin, sparfloxacin, pefloxacin mesylate, and gatifloxacin) at concentrations of 0.025%, 0.5%, and 0.1%. Each formulation was adjusted to different pH ranges (4.5, 7.0, and 8.0) and assessed for transcorneal penetration in vivo in rabbit's cornea (n=4 eyes) at three different volumes (12.5, 25, and 50 μL). Aqueous humor was aspirated through paracentesis after applying local anesthesia at 0, 5, 15, 30, 60, 120, and 240 minutes postdosing. The biosamples collected from a total of 27 groups were analyzed using liquid chromatography-tandem mass spectroscopy to determine transcorneal permeability of all four FQs individually.

RESULTS

Increase in concentration showed an increase in penetration up to 0.05%; thereafter, the effect of concentration was found to be dependent on volume of instillation as we observed a decrease in transcorneal penetration. The highest transcorneal penetration of all FQs was observed at pH 7.0 at concentration 0.05% followed by 0.025% at pH 4.5. Lastly, increasing the volume of instillation from 12.5 to 50 μL showed a significant fall in transcorneal penetration.

CONCLUSION

The study concludes that formulation factors showed discernible effect on transcorneal permeation; therefore, due emphasis should be given on drug development and design of ophthalmic formulation.

摘要

目的

药物的角膜通透性是评估局部制剂疗效的一个重要因素。药物从水性制剂中的角膜渗透受多种生理、物理化学和制剂因素的影响。在本研究中,我们使用眼科氟喹诺酮类药物(FQs)的卡式给药技术,研究了浓度、pH值和滴注体积等制剂因素对角膜渗透的影响。

材料与方法

使用四种同类眼科FQs(氧氟沙星、司帕沙星、甲磺酸培氟沙星和加替沙星)制备无菌混合制剂,浓度分别为0.025%、0.5%和0.1%。每种制剂调节至不同的pH范围(4.5、7.0和8.0),并在兔角膜(n = 4只眼)体内以三种不同体积(12.5、25和50 μL)评估角膜渗透情况。给药后0、5、15、30、60、120和240分钟,在局部麻醉后通过前房穿刺抽取房水。使用液相色谱 - 串联质谱法分析从总共27组收集的生物样品,以分别测定所有四种FQs的角膜通透性。

结果

浓度增加至0.05%时,渗透率增加;此后,发现浓度的影响取决于滴注体积,因为我们观察到角膜渗透降低。所有FQs在pH 7.0、浓度0.05%时角膜渗透率最高,其次是pH 4.5、浓度0.025%时。最后,将滴注体积从12.5 μL增加到50 μL时,角膜渗透率显著下降。

结论

该研究得出结论,制剂因素对角膜渗透有明显影响;因此,在眼科制剂的药物开发和设计中应给予充分重视。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/f6e7787649aa/dddt-10-811Fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/81113e77a70e/dddt-10-811Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/322312edeb9a/dddt-10-811Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/109eae12f60b/dddt-10-811Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/74a5e9195741/dddt-10-811Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/123df8f8ba7c/dddt-10-811Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/a1a23220c07a/dddt-10-811Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/a8c55fcfaabf/dddt-10-811Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/0cfa217856a2/dddt-10-811Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/a69741efd666/dddt-10-811Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/ea405a8e104a/dddt-10-811Fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/f6e7787649aa/dddt-10-811Fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/81113e77a70e/dddt-10-811Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/322312edeb9a/dddt-10-811Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/109eae12f60b/dddt-10-811Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/74a5e9195741/dddt-10-811Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/123df8f8ba7c/dddt-10-811Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/a1a23220c07a/dddt-10-811Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/a8c55fcfaabf/dddt-10-811Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/0cfa217856a2/dddt-10-811Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/a69741efd666/dddt-10-811Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/ea405a8e104a/dddt-10-811Fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc1/4769009/f6e7787649aa/dddt-10-811Fig11.jpg

相似文献

1
Comprehensive evaluation of formulation factors for ocular penetration of fluoroquinolones in rabbits using cassette dosing technique.采用灌胃给药技术对氟喹诺酮类药物在家兔眼部渗透的制剂因素进行综合评价。
Drug Des Devel Ther. 2016 Feb 22;10:811-23. doi: 10.2147/DDDT.S95870. eCollection 2016.
2
Delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination.以微乳为载体递送达氟沙星:制剂、评价、经角膜渗透和房水药物测定。
Drug Deliv. 2016;23(3):896-907. doi: 10.3109/10717544.2014.920432. Epub 2014 May 28.
3
Part II: Enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops.第二部分:与市售水性滴眼液相比,固体脂质纳米粒增强加替沙星的经角膜给药。
J Biomed Mater Res A. 2013 Jun;101(6):1828-36. doi: 10.1002/jbm.a.34467. Epub 2012 Nov 27.
4
The transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit eyes.含马来酸噻吗洛尔的市售眼科制剂在兔眼中的经角膜渗透情况。
J Ocul Pharmacol Ther. 2015 Feb;31(1):57-60. doi: 10.1089/jop.2014.0015.
5
Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops.制剂因素对加替沙星滴眼液体外角膜透过性的影响。
AAPS PharmSciTech. 2006 Jul 7;7(3):57. doi: 10.1208/pt070357.
6
Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.四种氟喹诺酮类药物滴眼后眼内穿透的比较。
Cornea. 2013 Jul;32(7):1046-51. doi: 10.1097/ICO.0b013e31828d6d9e.
7
Energy-dependent endocytosis is responsible for drug transcorneal penetration following the instillation of ophthalmic formulations containing indomethacin nanoparticles.能量依赖性内吞作用是导致含吲哚美辛纳米粒的眼用制剂滴眼后药物经角膜穿透的原因。
Int J Nanomedicine. 2019 Feb 18;14:1213-1227. doi: 10.2147/IJN.S196681. eCollection 2019.
8
Calculation of AQCmax: comparison of five ophthalmic fluoroquinolone solutions*.AQCmax的计算:五种眼科氟喹诺酮溶液的比较*
Curr Med Res Opin. 2008 Dec;24(12):3479-86. doi: 10.1185/03007990802480091.
9
Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea.含有西洛他唑作为抗青光眼药物的眼用制剂的制备及其兔角膜通透性的改善。
J Oleo Sci. 2010;59(8):423-30. doi: 10.5650/jos.59.423.
10
Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin.纳米尺寸树枝状聚胍基化转位蛋白用于增强加替沙星的溶解性、渗透性和递送
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5804-16. doi: 10.1167/iovs.10-5388. Epub 2010 May 19.

引用本文的文献

1
Gatifloxacin inducing apoptosis of stromal fibroblasts through cross-talk between caspase-dependent extrinsic and intrinsic pathways.加替沙星通过半胱天冬酶依赖性外源性和内源性途径之间的相互作用诱导基质成纤维细胞凋亡。
Int J Ophthalmol. 2019 Oct 18;12(10):1524-1530. doi: 10.18240/ijo.2019.10.02. eCollection 2019.
2
Pathogens and antibiotic sensitivities in endophthalmitis.眼内炎中的病原体及抗生素敏感性
Clin Exp Ophthalmol. 2017 Jul;45(5):481-488. doi: 10.1111/ceo.12910. Epub 2017 Jan 31.

本文引用的文献

1
Ophthalmic drug dosage forms: characterisation and research methods.眼科药物剂型:特性与研究方法
ScientificWorldJournal. 2014 Mar 18;2014:861904. doi: 10.1155/2014/861904. eCollection 2014.
2
Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.四种氟喹诺酮类药物滴眼后眼内穿透的比较。
Cornea. 2013 Jul;32(7):1046-51. doi: 10.1097/ICO.0b013e31828d6d9e.
3
Evaluation of pharmacological activities and assessment of intraocular penetration of an ayurvedic polyherbal eye drop (Itone™) in experimental models.
评价一种阿育吠陀复方眼用制剂(Itones)的药理学活性和眼内渗透作用的实验研究。
BMC Complement Altern Med. 2013 Jan 2;13:1. doi: 10.1186/1472-6882-13-1.
4
Reduction in drop size of ophthalmic topical drop preparations and the impact of treatment.眼科局部滴眼剂制剂的液滴大小减小及其治疗效果
J Adv Pharm Technol Res. 2011 Jul;2(3):192-4. doi: 10.4103/2231-4040.85540.
5
Development of novel in silico model to predict corneal permeability for congeneric drugs: a QSPR approach.用于预测同类药物角膜通透性的新型计算机模拟模型的开发:一种定量构效关系方法。
J Biomed Biotechnol. 2011;2011:483869. doi: 10.1155/2011/483869. Epub 2011 Feb 20.
6
Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.眼部药代动力学/药效学贝西沙星、莫西沙星和加替沙星在给色素兔局部给药后的表现。
J Ocul Pharmacol Ther. 2010 Oct;26(5):449-58. doi: 10.1089/jop.2010.0054.
7
Intraocular penetration of antimicrobial agents in ophthalmic infections and drug delivery strategies.眼科感染中抗菌药物的眼内渗透及药物递送策略。
Expert Opin Drug Deliv. 2009 Mar;6(3):255-70. doi: 10.1517/17425240902798119.
8
Cassette analysis of eight beta-blockers in bovine eye sclera, choroid-RPE, retina, and vitreous by liquid chromatography-tandem mass spectrometry.通过液相色谱-串联质谱法对牛眼巩膜、脉络膜-视网膜色素上皮、视网膜和玻璃体中的八种β受体阻滞剂进行盒式分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jan 15;877(3):253-60. doi: 10.1016/j.jchromb.2008.12.027. Epub 2008 Dec 24.
9
Calculation of AQCmax: comparison of five ophthalmic fluoroquinolone solutions*.AQCmax的计算:五种眼科氟喹诺酮溶液的比较*
Curr Med Res Opin. 2008 Dec;24(12):3479-86. doi: 10.1185/03007990802480091.
10
Ocular biodistribution of bevasiranib following a single intravitreal injection to rabbit eyes.单次玻璃体腔内注射贝伐西尼至兔眼后的眼内生物分布
Mol Vis. 2008 May 28;14:997-1005.